VitaLink Research was founded in 2004 by two Principal Investigators and three site operators with the dream of creating a site network comprised of world-class PIs and standardized processes.
The founders opened one new location per year to meet their clients’ demands for high-quality clinical trials in the pulmonary sector. This resulted in 11 dedicated clinical research sites between 2004 – 2013 throughout the Carolinas.
After an extensive review of the clinical trial site management industry, a Private Equity Firm inveseted into the future of VitaLink.
This included the build out of leading Board of Directors comprised of former senior executives in the CRO industry.
Operations and financial functions were centralized for all 10 sites. VitaLink Research builds a management team has extensive experience in patient recruitment, site management operations, quality and regulatory compliance. VitaLink also closed its first acquisition of Upstate Pharmaceutical Research.
VitaLink signs its second acquisition and acquires Comprehensive Clinical Trials in Florida. This acquisition helps grow VitaLink's therapeutic area focus beyond pulmonary to women's health. VitaLink continued it's growth by launching a new De Novo site in Columbia, SC in December
See All Locations